PROVEN TO PERFORM
Explore clinical data about the InterStimTM system and patient outcomes.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Explore clinical data about the InterStimTM system and patient outcomes.
Twenty years ago, Medtronic introduced sacral neuromodulation (SNM) and transformed how clinicians treat bladder and bowel control problems. Today, our therapies continue to demonstrate effective and lasting results in multiple studies.1,2
See evidence that demonstrates the efficacy of the InterStimTM system for reducing the symptoms of overactive bladder and non-obstructive urinary retention.1,3
SEE BLADDER SUMMARYView key data that prove the InterStimTM system can provide long-term relief of the symptoms of chronic fecal incontinence.2
SEE BOWEL SUMMARYTake convenient courses specifically designed for clinicians treating patients with OAB, non-obstructive urinary retention, and chronic fecal incontinence.
SEE COURSESSiegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018;Volume 199(1), 229–236.
Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234–245.
Medtronic InterStimTM Therapy Clinical Data Summary (2018).